Kng1 - kininogen 1 Gene
Also Known as Kng1l1; kininogen
Species: Rattus norvegicus
Summary
Predicted to enable cysteine-type endopeptidase inhibitor activity and signaling receptor binding activity. Predicted to be involved in several processes, including blood coagulation; negative regulation of blood coagulation; and negative regulation of endopeptidase activity. Predicted to be located in extracellular space. Used to study abdominal aortic aneurysm. Human ortholog(s) of this gene implicated in high molecular weight kininogen deficiency. Orthologous to human KNG1 (kininogen 1). [provided by Alliance of Genome Resources, Apr 2022]
Kng1 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001009628.1 | NP_001009628.1 | T-kininogen 2 precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
T-kininogen 2 |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-N4067 | Isochenodeoxycholic acid | Agonist | 99.90% | Unkown |
| HY-RS17640 | Kng1 Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS07411 | KNG1 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS24100 | Kng1 Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service